Clinical Trials List
Protocol NumberA6061021
Completed
2006-07-01 - 2007-12-30
Phase II
Terminated3
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Jong-Ling Fuh Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- Ching-Kuan Liu Division of Neurology
- Yuh-Cherng Guo Division of Neurology
- 盧相如 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
900 participants
